We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+0.94%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$904M
AUM Growth
+$9.28M
Cap. Flow
+$5.82M
Cap. Flow %
0.64%
Top 10 Hldgs %
31.24%
Holding
285
New
14
Increased
34
Reduced
142
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Industrials 18.12%
3 Consumer Discretionary 12.9%
4 Healthcare 11.73%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TURN
251
DELISTED
180 Degree Capital
TURN
$142K 0.02%
29,500
SRGA
252
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$138K 0.02%
1,283
-50
-4% -$5.86K
BRW
253
Saba Capital Income & Opportunities Fund
BRW
$336M
0
JQC icon
254
Nuveen Credit Strategies Income Fund
JQC
$702M
0
OXSQ icon
255
Oxford Square Capital
OXSQ
$151M
$116K 0.01%
22,000
+5,000
+29% +$26.2K
MSD
256
Morgan Stanley Emerging Markets Debt Fund
MSD
$147M
0
FEIM icon
257
Frequency Electronics
FEIM
$715M
$104K 0.01%
11,191
JPC icon
258
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
0
MIND icon
259
MIND Technology
MIND
$50.4M
$75K 0.01%
2,010
-320
-14% -$11.8K
SRL icon
260
Scully Royalty
SRL
$76.7M
$64K 0.01%
5,870
-1,100
-16% -$10.1K
ARLZ
261
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$54K 0.01%
16,487
ARTW icon
262
Arts-Way Manufacturing Co
ARTW
$11.4M
$53K 0.01%
17,775
DHF
263
BNY Mellon High Yield Strategies Fund
DHF
$171M
0
EQS icon
264
Equus Total Return
EQS
$14.9M
$32K ﹤0.01%
17,735
SMIT
265
DELISTED
Schmitt Industries Inc
SMIT
$28K ﹤0.01%
15,000
-5,000
-25% -$10.8K
CAS
266
DELISTED
A M Castle & Co
CAS
$21K ﹤0.01%
13,000
-2,500
-16% -$6.09K
AON icon
267
Aon
AON
$77.3B
-29,000
Closed -$3.03M
ATI icon
268
ATI
ATI
$27B
-32,534
Closed -$530K
BGMS
269
Bio Green Med Solution Inc
BGMS
$5.05M
0
-$7K
JEF icon
270
Jefferies Financial Group
JEF
$12.9B
-28,855
Closed -$418K
LKQ icon
271
LKQ Corp
LKQ
$6.58B
-10,500
Closed -$335K
MBOT icon
272
Microbot Medical
MBOT
$115M
-6
Closed -$3K
ORI icon
273
Old Republic International
ORI
$10.3B
-24,900
Closed -$455K
PM icon
274
Philip Morris
PM
$301B
-3,948
Closed -$387K
SLV icon
275
iShares Silver Trust
SLV
$28.1B
-12,000
Closed -$176K

Similar funds

Shufro Rose & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Shufro Rose & Co held 285 positions worth $904M, up 1% from $895M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q2 2016 filing shows 14 new, 34 increased, 142 reduced and 18 closed positions. Its largest new stake was Allergan plc: 87,846 shares worth $20.3M. The largest sale was Liberty Media Series C, an estimated $4.39M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Shufro Rose & Co's largest Q2 2016 buy was Allergan plc: 87,846 shares worth $20.3M.
  • Shufro Rose & Co added most to Chicago Bridge & Iron Nv in Q2 2016, an estimated $4.45M increase.
  • Shufro Rose & Co's biggest Q2 2016 reduction was Liberty Media Series C, cutting an estimated $4.39M.
  • Shufro Rose & Co fully exited SANDISK CORP in Q2 2016, selling an estimated $4.03M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $904M portfolio in Q2 2016.
  • Shufro Rose & Co opened 14 new positions and closed 18 in Q2 2016.
  • Shufro Rose & Co's portfolio value rose 1% quarter-over-quarter to $904M.

Based on Shufro Rose & Co's 13F filing for Q2 2016, filed 5 Aug 2016.